Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitomi Takada

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Biochemical and Biophysical Research Communications|August 1, 2013
N-Cadherin is a prospective cell surface marker of human mesenchymal stem cells that have high ability for cardiomyocyte differentiationHisako Ishimine, Norio Yamakawa, Mari Sasao, et al.
Plos One|September 10, 2015
Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New RegimensNobuharu Tamaki, Masayuki Kurosaki, Mayu Higuchi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 14, 2022
Early diagnosis of hepatic inflammation in Japanese nonalcoholic fatty liver disease patients using 3D MR elastographyYasuyuki Komiyama, Utaroh Motosugi, Shinya Maekawa, et al.
Oncology|June 6, 2023
Impact of Renal Function on the Prognosis of Patients Receiving Atezolizumab/Bevacizumab Combination Therapy and Lenvatinib Monotherapy for Unresectable Hepatocellular CarcinomaHitomi Takada, Koji Yamashita, Leona Osawa, et al.
Journal of Diabetes and Its Complications|May 18, 2004
Impact on mortality and incidence of end-stage renal disease of education and treatment at a diabetes center among patients with type 1 diabetes: comparison of two subgroups in the Japanese DERI cohortYasuko Uchigata, Keiko Asao, Masato Matsushima, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 16, 2014
L-carnitine Reduces Muscle Cramps in Patients With CirrhosisHiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Journal of Gastroenterology and Hepatology|February 22, 2023
Effect of a combination of pemafibrate and a mild low-carbohydrate diet on obese and non-obese patients with metabolic-associated fatty liver diseaseYuichiro Suzuki, Shinya Maekawa, Kohji Yamashita, et al.
Stem Cell Reports|March 7, 2017
A Role for KLF4 in Promoting the Metabolic Shift via TCL1 during Induced Pluripotent Stem Cell GenerationKen Nishimura, Shiho Aizawa, Fransiska Liliani Nugroho, et al.
Plos One|June 19, 2018
Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinomaHitomi Takada, Masayuki Kurosaki, Hiroyuki Nakanishi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2018
Prediction of Hepatocellular Carcinoma After Sustained Virological Responses Using Magnetic Resonance ElastographyMayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Biochemical and Biophysical Research Communications|August 1, 2013
N-Cadherin is a prospective cell surface marker of human mesenchymal stem cells that have high ability for cardiomyocyte differentiationHisako Ishimine, Norio Yamakawa, Mari Sasao, et al.
Plos One|September 10, 2015
Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New RegimensNobuharu Tamaki, Masayuki Kurosaki, Mayu Higuchi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 14, 2022
Early diagnosis of hepatic inflammation in Japanese nonalcoholic fatty liver disease patients using 3D MR elastographyYasuyuki Komiyama, Utaroh Motosugi, Shinya Maekawa, et al.
Oncology|June 6, 2023
Impact of Renal Function on the Prognosis of Patients Receiving Atezolizumab/Bevacizumab Combination Therapy and Lenvatinib Monotherapy for Unresectable Hepatocellular CarcinomaHitomi Takada, Koji Yamashita, Leona Osawa, et al.
Journal of Diabetes and Its Complications|May 18, 2004
Impact on mortality and incidence of end-stage renal disease of education and treatment at a diabetes center among patients with type 1 diabetes: comparison of two subgroups in the Japanese DERI cohortYasuko Uchigata, Keiko Asao, Masato Matsushima, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 16, 2014
L-carnitine Reduces Muscle Cramps in Patients With CirrhosisHiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Journal of Gastroenterology and Hepatology|February 22, 2023
Effect of a combination of pemafibrate and a mild low-carbohydrate diet on obese and non-obese patients with metabolic-associated fatty liver diseaseYuichiro Suzuki, Shinya Maekawa, Kohji Yamashita, et al.
Stem Cell Reports|March 7, 2017
A Role for KLF4 in Promoting the Metabolic Shift via TCL1 during Induced Pluripotent Stem Cell GenerationKen Nishimura, Shiho Aizawa, Fransiska Liliani Nugroho, et al.
Plos One|June 19, 2018
Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinomaHitomi Takada, Masayuki Kurosaki, Hiroyuki Nakanishi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2018
Prediction of Hepatocellular Carcinoma After Sustained Virological Responses Using Magnetic Resonance ElastographyMayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Pageof 8